Neuroxelin (48 mg Vial)
Neuroxelin is a proprietary neuropeptide blend studied for cognitive support, neuroprotection, and neural recovery. Formulations typically combine peptides such as Cerebrolysin-derived fractions, Semax, Selank, and/or DSIP. Exact composition varies by supplier — always confirm on your vial label.
⚡ QUICKSTART HIGHLIGHTS
Dosing & Reconstitution Guide
Representative Composition (per vial)
| Component | Typical Amount | Role |
|---|---|---|
| Cerebrolysin fraction / neuropeptide mix | ~30 mg | Neuroprotection; BDNF-like activity; neural repair |
| Semax or ADAMAX | ~10 mg | Cognitive enhancement; BDNF upregulation |
| Selank or DSIP | ~8 mg | Anxiolytic; sleep architecture support |
Dosing Protocol
| Phase | Daily Dose | Frequency | Route |
|---|---|---|---|
| Starting | 1–2 mL/day | Once daily | IV push, IM, or sub-Q |
| Standard cycle | 2–5 mL/day | Once daily | 10–14 day course |
Administration
- Reconstitute with 3.0 mL sterile or bacteriostatic water.
- Standard course: 10–21 consecutive daily injections, then break.
- IV push: administer slowly over 2–3 minutes.
- IM or sub-Q: standard injection technique.
How This Works
Neuroxelin is designed as a broad-spectrum neuropeptide support blend. The neuropeptide fraction (often cerebrolysin-derived) provides neurotrophic factor-like activity — BDNF-mimetic, NGF-mimetic, and CNTF-mimetic effects that support neuronal survival, synaptogenesis, and plasticity. Cognitive peptide components (Semax/ADAMAX class) upregulate BDNF directly via ACTH-fragment mechanism and modulate dopaminergic/serotonergic neurotransmission.
Anxiolytic components (Selank/DSIP) address the anxiety-cognition interaction — reducing cortisol-driven cognitive impairment while supporting sleep architecture, during which neural consolidation occurs. The combination aims to address neuroplasticity, neuroprotection, and cognitive performance from multiple angles simultaneously.
Potential Benefits & Side Effects
Potential Benefits
- Multi-mechanism: neuroprotection + BDNF upregulation + anxiolytic + sleep support.
- May be particularly relevant for post-injury neural recovery research.
- Cognitive enhancement potential via complementary mechanisms.
- Convenient combination vs multiple separate injections.
- Cerebrolysin component has the strongest published clinical data in this class.
Side Effect Profile
- Adverse effects depend heavily on specific formulation — verify with supplier.
- Possible: dizziness, agitation, insomnia (dose-dependent — cerebrolysin component).
- DSIP component: mild headache possible.
- Semax component: mild stimulant profile — avoid evening dosing.
- Rare: allergic reactions to porcine-derived fractions (if cerebrolysin-based).
- Limited independent safety data for the specific combination.
Storage Instructions
| State | Temperature | Duration |
|---|---|---|
| Lyophilized | −20°C (−4°F) | −20°C, up to 24 months |
| Reconstituted | 2–8°C | Up to 14 days (use fresh if sterile water used) |